ArticleIn vivo (Athens, Greece)
Impact of Cirrhosis Outcome Risk Estimator Score on Outcomes Following Pancreatectomy for Resectable Pancreatic Ductal Adenocarcinoma.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimThe Cirrhosis Outcome Risk Estimator (CORE) score is a novel model designed to predict the risk of liver disease. However, data regarding the prognostic utility of the CORE score in patients with resectable pancreatic ductal adenocarcinoma (R-PDAC) remain scarce. This study aimed to evaluate the utility of the CORE score as a prognostic stratification tool for R-PDAC. PATIENTS AND
methodsWe retrospectively analyzed 242 patients who underwent pancreatectomy for R-PDAC between January 2009 and December 2023. Patients were stratified into two groups based on their preoperative CORE scores. Multivariate analyses were performed to identify independent predictors of recurrence-free survival (RFS) and overall survival (OS), comparing perioperative outcomes between the groups.
resultsOf the 242 patients, 73 (30.2%) were classified into the high CORE score group (score >0.9). Patients in the high CORE score group exhibited significantly worse five-year RFS (18.0%
conclusionThe CORE score is a robust, simple preoperative predictor of survival following pancreatectomy for R-PDAC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.